Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cardiovascular Blood Fibrinolysis / Thrombolysis

Human PAI1 ELISA Kit (SERPINE1) (ab269373)

Price and availability

368 544 ₸

Availability

Order now and get it on Wednesday February 24, 2021

Human PAI1 ELISA Kit (SERPINE1) (ab269373)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • One-wash 90 minute protocol
  • Sensitivity: 16 pg/ml
  • Range: 31.25 pg/ml - 2000 pg/ml
  • Sample type: Cell culture supernatant, Cell Lysate, Cit plasma, EDTA Plasma, Hep Plasma, Serum
  • Detection method: Colorimetric
  • Assay type: Sandwich (quantitative)
  • Reacts with: Human

You may also be interested in

Native Human Plasminogen protein (ab62493)
Product image
Anti-HC-II antibody (ab232859)
Product image
Recombinant mouse PAI1 protein (ab93068)
Product image
Recombinant human HC-II protein (ab191977)

Overview

  • Product name

    Human PAI1 ELISA Kit (SERPINE1)
    See all PAI1 kits
  • Detection method

    Colorimetric
  • Precision

    Intra-assay
    Sample n Mean SD CV%
    Serum 3 3.3%
    Inter-assay
    Sample n Mean SD CV%
    Serum 8 3.8%
  • Sample type

    Cell culture supernatant, Serum, Cell Lysate, Hep Plasma, EDTA Plasma, Cit plasma
  • Assay type

    Sandwich (quantitative)
  • Sensitivity

    16 pg/ml
  • Range

    31.25 pg/ml - 2000 pg/ml
  • Recovery

    Sample specific recovery
    Sample type Average % Range
    Cell culture supernatant 96 88% - 102%
    Serum 90 86% - 95%
    Cell Lysate 108 108% - 111%
    Hep Plasma 100 97% - 103%
    EDTA Plasma 96 94% - 97%
    Cit plasma 103 97% - 107%
  • Assay time

    1h 30m
  • Assay duration

    One step assay
  • Species reactivity

    Reacts with: Human
  • Product overview

    Human PAI1 ELISA Kit (SERPINE1) (ab269373) is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of PAI1 (SERPINE1) protein in cell culture supernatant, cell lysate, edta plasma, hep plasma, serum, and cit plasma. It uses our proprietary SimpleStep ELISA® technology. Quantitate Human PAI1 (SERPINE1) with 16 pg/ml sensitivity.


    SimpleStep ELISA® technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA® plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA® protocol summary in the image section for further details. Our SimpleStep ELISA® technology provides several benefits:


            - Single-wash protocol reduces assay time to 90 minutes or less
            - High sensitivity, specificity and reproducibility from superior antibodies
            - Fully validated in biological samples
            - 96-wells plate breakable into 12 x 8 wells strips


    A 384-well SimpleStep ELISA® microplate (ab203359) is available to use as an alternative to the 96-well microplate provided with SimpleStep ELISA® kits.


    Assay Specificity: This kit recognizes both native and recombinant human PAI1 protein in serum, plasma, cell culture supernatant, and cell extract samples only. Tissue extract samples have not been tested with this kit.


    Species Reactivity: This kit recognizes human PAI1 protein.


    Other species reactivity was determined by measuring 1:20 (dilution) serum samples of various species, interpolating the protein concentrations from the human standard curve, and expressing the interpolated concentrations as a percentage of the protein concentration in human serum assayed at the same dilution.


    Monkey serum was 100% cross-reactive.


    Reactivity


     

  • Notes

    Plasminogen activator inhibitor-1 (PAI-1) or SERPINE1is encoded by the SERPINE1 gene. The PAI-1 protein is a serine protease inhibitor (serpin) that functions as the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA). The inhibition of tPA and uPA leads to increased occurrence and persistence of blood clots to form.

    Abcam has not and does not intend to apply for the REACH Authorisation of customers’ uses of products that contain European Authorisation list (Annex XIV) substances.
    It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

  • Platform

    Pre-coated microplate (12 x 8 well strips)

Properties

  • Storage instructions

    Store at +4°C. Please refer to protocols.
  • Components 1 x 96 tests
    10X Human PAI1 (SERPINE1) Capture Antibody 1 x 600µl
    10X Human PAI1 (SERPINE1) Detector Antibody 1 x 600µl
    10X Wash Buffer PT (ab206977) 1 x 20ml
    50X Cell Extraction Enhancer Solution (ab193971) 1 x 1ml
    5X Cell Extraction Buffer PTR (ab193970) 1 x 10ml
    Antibody Diluent 5BI 1 x 6ml
    Human PAI1 (SERPINE1) Lyophilized Recombinant Protein 2 vials
    Plate Seals 1 unit
    Sample Diluent NS (ab193972) 1 x 50ml
    SimpleStep Pre-Coated 96-Well Microplate (ab206978) 1 unit
    Stop Solution 1 x 12ml
    TMB Development Solution 1 x 12ml
  • Research areas

    • Cardiovascular
    • Blood
    • Fibrinolysis / Thrombolysis
    • Cell Biology
    • Proteolysis / Ubiquitin
    • Protease inhibitors
    • Serine protease inhibitors
    • SERPINs
    • Cancer
    • Tumor biomarkers
    • Other
    • Metabolism
    • Types of disease
    • Metabolic disorders
  • Function

    This inhibitor acts as 'bait' for tissue plasminogen activator, urokinase, and protein C. Its rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis.
  • Tissue specificity

    Found in plasma and platelets and in endothelial, hepatoma and fibrosarcoma cells.
  • Involvement in disease

    Defects in SERPINE1 are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1D) [MIM:613329]. It is a hematologic disorder characterized by increased bleeding after trauma, injury, or surgery. Affected females have menorrhagia. The bleeding defect is due to increased fibrinolysis of fibrin blood clots due to deficiency of plasminogen activator inhibitor-1, which inhibits tissue and urinary activators of plasminogen.
    Note=High concentrations of SERPINE1 seem to contribute to the development of venous but not arterial occlusions.
  • Sequence similarities

    Belongs to the serpin family.
  • Post-translational
    modifications

    Inactivated by proteolytic attack of the urokinase-type (u-PA) and the tissue-type (TPA), cleaving the 369-Arg-
    -Met-370 bond.
  • Cellular localization

    Secreted.
  • Target information above from: UniProt accession P05121 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Alternative names

    • Clade E
    • Endothelial plasminogen activator inhibitor
    • Nexin
    • Nexin plasminogen activator inhibitor type 1
    • PAI
    • PAI 1
    • PAI-1
    • PAI1_HUMAN
    • PLANH1
    • Plasminogen activator inhibitor 1
    • Plasminogen activator inhibitor type 1
    • Serine (or cysteine) proteinase inhibitor
    • Serine (or cysteine) proteinase inhibitor clade E (nexin plasminogen activator inhibitor type 1) member 1
    • Serine proteinase inhibitor clade E member 1
    • serpin
    • Serpin E1
    • Serpin peptidase inhibitor clade E
    • Serpin peptidase inhibitor clade E (nexin plasminogen activator inhibitor type 1) member 1
    • Serpine 1
    • SERPINE1
    see all
  • Database links

    • Entrez Gene: 5054 Human
    • Omim: 173360 Human
    • SwissProt: P05121 Human
    • Unigene: 414795 Human
    • Unigene: 713079 Human

    Images

    • SimpleStep ELISA Protocol Diagram
      SimpleStep ELISA Protocol Diagram

      SimpleStep ELISA technology allows the formation of the antibody-antigen complex in one single step, reducing assay time to 90 minutes. Add samples or standards and antibody mix to wells all at once, incubate, wash, and add your final substrate. See protocol for a detailed step-by-step guide.

    • Human PAI1 standard curve comparison
      Human PAI1 standard curve comparison

      Standard Curve comparison between human PAI1 SimpleStep ELISA kit and traditional ELISA kit from leading competitor. SimpleStep ELISA kit shows increased sensitivity.

    • Example of human PAI1 standard curve in Sample Diluent NS.
      Example of human PAI1 standard curve in Sample Diluent NS.

      The PAI1 standard curve was prepared as described. Raw data values are shown in the table. Background-subtracted data values (mean +/- SD) are graphed.

    • Example of human PAI1 standard curve in Sample Diluent NS.
      Example of human PAI1 standard curve in Sample Diluent NS.

      The PAI1 standard curve was prepared as described. Raw data values are shown in the table. Background-subtracted data values (mean +/- SD) are graphed.

    • . Example of human PAI1 standard curve in 1X Cell Extraction Buffer PTR.
      . Example of human PAI1 standard curve in 1X Cell Extraction Buffer PTR.

      The PAI1 standard curve was prepared as described. Raw data values are shown in the table. Background-subtracted data values (mean +/- SD) are graphed.

    • Example of human PAI1 standard curve in 1X Cell Extraction Buffer PTR.
      Example of human PAI1 standard curve in 1X Cell Extraction Buffer PTR.

      The PAI1 standard curve was prepared as described. Raw data values are shown in the table. Background-subtracted data values (mean +/- SD) are graphed.

    • Linearity of dilution.
      Linearity of dilution.

      Linearity of dilution is determined based on interpolated values from the standard curve. Linearity of dilution defines a sample concentration interval in which interpolated target concentrations are directly proportional to sample dilution.

      Native PAI1 was measured in the following biological samples in a 2-fold dilution series. Sample dilutions are made in Sample Diluent NS.

    • Linearity of dilution.
      Linearity of dilution.

      Native PAI1 was measured in the following biological samples in a 2-fold dilution series. Sample dilutions are made in Sample Diluent NS.

    • Linearity of dilution.
      Linearity of dilution.

      Native PAI1 was measured in the following biological samples in a 2-fold dilution series. Sample dilutions are made in Sample Diluent NS.

    • Linearity of dilution.
      Linearity of dilution.

      Native PAI1 was measured in the following biological samples in a 2-fold dilution series. Sample dilutions are made in 1X Cell Extraction Buffer PTR.

    • Interpolated concentrations of native PAI1 in human serum and plasma samples.
      Interpolated concentrations of native PAI1 in human serum and plasma samples.

      The concentrations of PAI1 were measured in duplicates, interpolated from the PAI1 standard curves and corrected for sample dilution. Undiluted samples are as follows: serum 5%, plasma (citrate) 5%, plasma (EDTA) 10%, and plasma (heparin) 5%. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean PAI1 concentration was determined to be 32.4 ng/mL in serum, 36.6 ng/mL in plasma (citrate), 11.1 ng/mL in plasma (EDTA), and 10.1 ng/mL in plasma (heparin).

    • Interpolated concentrations of native PAI1 in human stimulated PBMC cell culture supernatant and unstimulated PBMC cell culture supernatant samples.
      Interpolated concentrations of native PAI1 in human stimulated PBMC cell culture supernatant and unstimulated PBMC cell culture supernatant samples.

      The concentrations of PAI1 were measured in duplicates, interpolated from the PAI1 standard curves and corrected for sample dilution. Undiluted samples are as follows: stimulated PBMC cell culture supernatant 50% and unstimulated PBMC cell culture supernatant 50%. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean PAI1 concentration was determined to be 1,896 pg/mL in stimulated PBMC cell culture supernatant and 642 pg/mL in unstimulated PBMC cell culture supernatant.

    • Interpolated concentrations of native PAI1 in HUVEC cell culture supernatant, and HepG2 cell culture supernatant samples.
      Interpolated concentrations of native PAI1 in HUVEC cell culture supernatant, and HepG2 cell culture supernatant samples.

      The concentrations of PAI1 were measured in duplicates, interpolated from the PAI1 standard curves and corrected for sample dilution. Undiluted samples are as follows: HUVEC cell culture supernatant 1:2,000 and HepG2 cell culture supernatant 1:400. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean PAI1 concentration was determined to be 2,061 ng/mL in HUVEC cell culture supernatant and 739 ng/mL in HepG2 cell culture supernatant.

    • Interpolated concentrations of native PAI1 in HUVEC cell extract and HepG2 cell extract samples based on a 500 µg/mL and 50 µg/mL extract load, respectively.
      Interpolated concentrations of native PAI1 in HUVEC cell extract and HepG2 cell extract samples based on a 500 µg/mL and 50 µg/mL extract load, respectively.

      The concentrations of PAI1 were measured in duplicate and interpolated from the PAI1 standard curve and corrected for sample dilution. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean PAI1 concentration was determined to be 677 pg/mL in HUVEC cell extract and 989 pg/mL in HepG2 cell extract.

    • Serum from ten individual healthy human female donors was measured in duplicate.
      Serum from ten individual healthy human female donors was measured in duplicate.

      Interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean PAI1 concentration was determined to be 24 ng/mL with a range of 8 – 59 ng/mL.

    • Assay sensitivity.
      Assay sensitivity.

      The MDD was determined by calculating the mean of zero standard replicates and adding 2 standard deviations then extrapolating the corresponding concentration.

    • Sandwich ELISA - Human PAI1 ELISA Kit (SERPINE1) (ab269373)
      Sandwich ELISA - Human PAI1 ELISA Kit (SERPINE1) (ab269373)
      To learn more about the advantages of recombinant antibodies see here.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Alternative products to Human PAI1 ELISA Kit (SERPINE1) (ab269373)

    •  
    • Product image

      Human PAI1 Antibody Pair - BSA and Azide free (ab270375)

      Applications:

    Clear all

    Recently viewed products

    •  
    • Product image

      Anti-RPS24 antibody [EPR16017(B)] (ab196652)

    •  
    • Product image

      Anti-PCSK2 antibody [EPR23578-19] (ab274418)

    •  
    • Product image

      Anti-MMP8 antibody [EP1252Y] (ab81286)

    •  
    • Product image

      Anti-IL2 Receptor beta/p75 antibody [EPR22892-2] (ab263906)

    •  
    • Product image

      Anti-ATP6V1A antibody (ab137574)

    •  
    • Product image

      Anti-Varicella Zoster Virus gH antibody [SG3] (ab252704)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.